Amit K. Garg

Reactive oxygen intermediates in TNF signaling.

Nuclear factor-kappa B as a predictor of treatment response in breast cancer.

T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.

Chemosensitization and radiosensitization of tumors by plant polyphenols.

Radiation proctopathy in the treatment of prostate cancer.

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.

Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy.

A framework for evaluation of deformable image registration spatial accuracy using large landmark point sets.

Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation.

Endodontic treatment of a maxillary first molar having three mesiobuccal canals with the aid of spiral computed tomography: a case report.

Purification and identification of endogenous polySUMO conjugates.

Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience.

Nocebo side-effects in cancer treatment.

Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.

The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.